Bio-Amd Inc (BIAD) 0.0310 $BIAD Bio-AMD, Inc.; COAG

New Post Public Reply Private Reply Replies (0) Message Board

Jun 20, 2016 at 4:05 AM

Bio-Amd Inc (BIAD) 0.0310 $BIAD

Bio-AMD, Inc.; COAG PT/INR Point of Care Hemostasis Project & Patent Update
Marketwire Canada - Thu May 12, 7:01AM CDT
DARESBURY, UNITED KINGDOM--(Marketwired - May 12, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

(OTCQB: BIAD) here provides an update on its PT/INR COAG project and on other matters around its business.

Bio-AMD, Inc.: MIDS Patent Grant in People's Republic of China
Marketwired - Thu Mar 03, 7:30AM CST
Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company"

(OTCQB: BIAD) is pleased to confirm that it has received a Certificate of Grant of a patent in the People's Republic of China ("PRC"

for our Magnetic Immunoassay Detection System (MIDS) technology platform.

Bio-AMD, Inc.: First MIDS Patent Grant Likely, Shareholder Update
ACCESSWIRE - Mon Jan 11, 7:30AM CST
DARESBURY, ENGLAND / ACCESSWIRE / January 11, 2016 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company" OTCQB: BIAD) is pleased to provide an update on progress for shareholders.

Bio-AMD, Inc.; United States Patent Granted for PT/INR Technology
ACCESSWIRE - Thu Jul 16, 7:45AM CDT
LONDON, ENGLAND / ACCESSWIRE / July 16, 2015 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company"

(OTCQB: BIAD), is pleased to announce that it has recently received formal notice of a grant of a United States Patent ("Grant"

for its Low Volume Assay Apparatus used in its point of care system for the measurement of Prothrombin Time / International Normalized Ratio ("PT/INR"

.

Bio-AMD, Inc.; Ethics Approval for Patient Testing Study
ACCESSWIRE - Thu Jul 02, 7:45AM CDT
LONDON, ENGLAND, UK /ACCESSWIRE / July 2, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

(OTCQB: BIAD), is pleased to announce it has obtained a "favourable ethical opinion" from the North West Centre of Research Ethics Committees of the UK's National Research Ethics Service (together, "NRES"

, enabling it to undertake sample testing from patients as part of its development program.

Bio-AMD, Inc.; MIDS Proof of Market Report
ACCESSWIRE - Mon Jun 01, 7:37AM CDT
FLONDON, ENGLAND / ACCESSWIRE / June 1, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company"

(OTCQB: BIAD), is pleased to announce that it has recently received an independent Proof of Market report ("Report"

, part-funded by a UK government grant, on its novel Magnetic Immunoassay Detection System ("MIDS"

technology.

Bio-AMD, Inc.; Implementation of ISO9001 and ISO 13485 Quality Standards
ACCESSWIRE - Thu May 21, 7:45AM CDT
LONDON, ENGLAND / ACCESSWIRE / May 21, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company" OTCQB: BIAD) is pleased to announce that it is to formalise implementation of the International Organisation for Standardization quality standards ISO 9001:2008 and ISO 13485:2012.

Bio-AMD, Inc.; Grant Funded Technical Support from the University of Liverpool
ACCESSWIRE - Tue May 05, 7:45AM CDT
LONDON, ENGLAND /ACCESSWIRE / May 5, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company"

(OTCQB: BIAD), is pleased to announce that it has recently received grant funded assistance from the University of Liverpool to assist in the further development of its micro-fluidic technology, especially in relation to our proposed Magnetic Immunoassay Detection System ("MIDS"

program.

Bio-AMD, Inc.; General Update and MIDS Plans
eTeligis - Tue Apr 14, 12:11AM CDT
LONDON, ENGLAND, United States, via ETELIGIS INC., 03/31/2015 - - Bio-AMD, Inc. (OTCQB: BIAD) and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

provides an update on progress and the Company's plans for 2015. More information is available in the Company's 10K annual filing dated March 30, 2015.

Bio-AMD, Inc.; General Update & MIDS Plans
ACCESSWIRE - Tue Mar 31, 7:31AM CDT
LONDON, ENGLAND / ACCESSWIRE / March 31, 2015 / Bio-AMD, Inc. (OTCQB:BIAD) and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company"

provides an update on progress and the Company's plans for 2015. More information is available in the Company's 10K annual filing dated March 30, 2015.

Bio-AMD, Inc. Agreement with Sysmex & General Update
ACCESSWIRE - Tue Jan 27, 7:46AM CST
LONDON, ENGLAND / ACCESSWIRE / January 27, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

(OTCQB: BIAD) provides an update on the Company's plans for 2015.

Bio-AMD, Inc., Innovate UK Offer of Funding Assistance
ACCESSWIRE - Wed Nov 19, 8:16AM CST
LONDON, ENGLAND / ACCESSWIRE / November 19, 2014 / Bio-AMD, Inc. and Bio AMD Limited, our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

(OTCQB: BIAD) is pleased to announce that it has received an offer of a funding award assistance from Innovate UK, the UK's innovation agency, for a Proof of Market report covering the Company's Magnetic Immunoassay Detection System ("MIDS"

.

Bio-AMD, Inc.; Develops Multi-Reagent Microfluidic Test Strip
ACCESSWIRE - Tue Oct 07, 8:46AM CDT
LONDON, ENGLAND / ACCESSWIRE / October 7, 2014 / Bio-AMD, Inc. and Bio AMD Limited, our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"

(OTCQB: BIAD), is pleased to announce that it has successfully carried out internal testing on what it believes to be a novel microfluidic test strip capable of automated, multiple reagent immunoassay testing at the Point of Care ("POC"

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cut Winter Heating Costs with Townsend's Rebate Help

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

China Southern Airlines Marks 70th Anniversary in NYC

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Endurance Energy's Modular Tech Revs Up Southeast Asia

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Timur Turlov Leads FIDE with Chess and Digital Focus

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...